Gabapentin Tablet
Product Images NDC 63629-7308

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-7308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Equation)

This text provides formulas for calculating estimated creatinine clearance based on age and weight. It includes an adjustment factor for female patients.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This text provides information about a comparative study involving different doses of Gabapentin, including a fixed dose and a titrated dose, along with a placebo group. The mean pain scores at baseline and across various weeks are also mentioned in the data.*

FDA Label Image

Figure3 (Figure3)

This text provides data on the proportion of responders in controlled studies for postherpetic neuralgia (PHN) treatment. It includes percentages of responders, statistical significance values, and the comparison of pain score reductions between the studies. The data also mentions the treatment groups with their respective amounts in GBP (British Pounds).*

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Glenmarklogo1 (Glenmarklogo1)

Not available.*

FDA Label Image

Glenmarklogo2 (Glenmarklogo2)

FDA Label Image

Label (Lbl636297308)

This is a description of a medication called Gabapentin, containing 800 mg of the active ingredient per tablet, and is film-coated. It warns against causing dizziness and advises keeping it out of reach of children. The storage conditions of the tablets are indicated, along with the recommendation for dispensing in child-resistant packaging. The text also refers to package insert information and the necessity for pharmacists to provide a Medication Guide to each patient.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.